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Summary  
Infection with the human immunodeficiency virus (HIV) results in immunosuppression and 
depletion of circulating CD4 + T cells. Since the thymus is the primary organ in which T cells 
mature it is of interest to examine the effects of HIV infection in this tissue. HIV infection has 
been demonstrated in the thymuses of infected individuals and thymocytes have been previously 
demonstrated to be susceptible to HIV infection both in vivo, using the SCID-hu mouse, and 
in vitro. The present study sought o determine which subsets of thymocytes were infected in 
the SCID-hu mouse modal and to evaluate HIV-related alterations in the thymic microenvironment. 
Using two different primary HIV isolates, infection was found in CD4 +/CD8 + double positive 
thymocytes a well as in both the CD4 + and CD8 + single positive subsets of thymocytes. The 
kinetics of infection and resulting viral burden differed among the three thymocyte subsets and 
depended on which HIV isolate was used for infection. Thymic epithelial (TE) cells were also 
shown to endocytose virus and to often contain copious amounts of viral RNA in the cytoplasm 
by in situ hybridization, although productive infection of these cells could not be definitively 
shown. Furthermore, degenerating TE cells were observed even without detection of HIV in 
the degenerating cells. Two striking morphologic patterns of infection were seen, involving either 
predominantly thymocyte infection and depletion, or TE cell involvement with detectable 
cytoplasmic viral RNA and/or TE cell toxicity. Thus, a variety of cells in the human thymus 
is susceptible to HIV infection, and infection with HIV results in a marked isruption of the 
thymic microenvironment leading to depletion of thymocytes and degeneration f TE ceils. 
D epletion of mature CD4 + T lymphocytes associated with severe immunosuppression is characteristic of in- 
fection with the HIV (1). The mechanism of CD4 § T cell 
depletion have been postulated to include direct lytic infec- 
tion by HIV (2); destruction of uninfected cells coated with 
the soluble viral envelope protein, gp120, by cytotoxic effector 
cells and antibody-dependent cellular cytotoxicity (3, 4); apop- 
tosis of CD4 + T cells due to abnormal signaling by HIV 
proteins (5); or autoimmune phenomena (6). HIV infection 
of either bone marrow or thymic precursor cells leading to 
their destruction orfailure to give rise to more mature progeny 
could also contribute to peripheral blood CD4 + T cell 
depletion. In this regard, this laboratory and others (7, 8) 
have previously shown that immature thymocyte precursors 
as well as CD34 + bone marrow progenitor cells (9) can be 
infected with HIV in vitro. It has also been demonstrated 
that CD34 + progenitor cells are infected in vivo in some in- 
dividuals (10) and that human thymocytes can be reprodu- 
cibly infected with primary isolates of HIV in vivo using the 
SCID-hu mouse model (11). 
Failure to regenerate mature T lymphocytes could also occur 
if the thymic microenvironment is damaged by HIV infec- 
tion. Autopsy and biopsy studies have demonstrated that the 
thymus in HIV-infected individuals i  abnormal with efface- 
ment of the medulla nd cortex, marked involution, and deple- 
tion of epithelial elements as well as thymocytes (12-16). 
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It has been postulated but not demonstrated that the thy- 
mic (TE) 1 cell may be a primary target for HIV-induced 
injury (15). 
The SCID-hu xenograft mouse model has been developed 
as a tool for studying ongoing human thymopoiesis (17, 18, 
and for a review see reference 19). Mature lymphocytes within 
the SCID-hu mouse have been shown to be functionally and 
phenotypically normal (20, 21), and the morphology of the 
SCID-hu thymus appears similar to the normal human 
thymus, with distinct medullary and cortical compartments, 
Hassall's corpuscles, and an appropriate distribution of ma- 
ture and immature thymocytes (17). 
In the present study, the SCID-hu mouse was employed 
to further delineate the subsets of thymocytes that are sus- 
ceptible to in vivo infection with HIV and to examine the 
effects of HIV on the thymic microenvironment. This study 
demonstrates that both CD4 + and CD8 § single positive 
(SP) thymocytes as well as CD4+/CD8 + double positive 
(DP) cells are infected with HIV in the SCID-hu thymus. 
Furthermore, we demonstrate not only alterations in the 
microenvironment of the HIV-infected thymus but also the 
presence of HIV within TE cells. 
Materials and Methods 
Infection of SCID-hu Mice. The SCID-hu chimeric mice used 
in this study are C.B-17 scid/scid mice into which small pieces (ml 
mm 3 each) of human second trimester fetal thymus and liver have 
been implanted under the renal capsule. Over several months, the 
tissues vascularize, fuse, and mature into a thymic structure that 
supports ongoing human thymopoiesis (17, 18). SCID-hu mice (SyS- 
temix, Inc., Palo Alto, CA) were used 4-6 mo after implantation 
of human tissue. To minimize variables, each separate experiment 
used littermate mice reconstituted with tissue from the same fetal 
donor. Six different experiments u ing over 65 mice were performed 
for this study. Mice were anesthetized and a flank incision made 
to expose the kidney with the thymic implant. Sterile normal sa- 
line or 400-4,000 tissue culture infectious doses0 of HIV (in a 
small volume) was injected irectly into the thymus and the flank 
incision closed. Two different primary HIV viral isolates, the molecu- 
larly cloned JK-CSF (22) and the early passage highly cytopathic 
isolate SM, were used in these xperiments. At varying times after 
infection, individual mice were killed and the human thymus re- 
moved. Small pieces of tissue were placed immediately in fixative 
for immunohistochemistry (IHC), in situ hybridization (ISH), and 
transmission electron microscopy (TEM). Total thymocytes har- 
vested from the remaining tissue by gentle mechanical dissociation 
were immediately stained for phenotypic analysis and cell sorting. 
Because the amount of thymic tissue from which thymocytes were 
harvested varied according to the initial size of the particular thymus 
and the amount of tissue taken for histologic studies, variable 
numbers of thymocytes were obtained from each mouse, so that 
total thymocyte c ll counts were not meaningful when evaluating 
the effect of infection on thymocyte depletion. However, depletion 
was evaluated uring careful histologic examination of various 
thymic samples. Additionally, FACS | analysis gives reproducible 
t Abbreviations used in thispatxor: DN, double negative; DP, double positive; 
IHC, immunohistochemistry; ISH, in situ hybridization; SP,single positive; 
TE, thymic epithelial; TEM, transmission electron microscopy; TN, triple 
negative. 
results regarding the CD4/CD8 staining pattern of total thymo- 
cytes so that preferential depletion of thymocyte subsets could be 
evaluated. 
Fluorescence Activated Cell Sorting and Analysis. Total thymocytes 
were incubated on ice with anti-CD4 (anti-Leu 3a + 3b FITC, 
Becton Dickinson & Co., Mountain View, CA) followed by staining 
with anti-CD8 (anti-Leu 2a PE, Becton Dickinson & Co.) according 
to the manufacturer's recommendations. Thymocytes were stained 
with a nonreactive, isotype-matched mAb for background controls. 
Labeled thymocytes were sorted using an Epics C flow cytometer 
(Coulter Corp., Hialeah, FL) equipped with a 5W argon laser with 
a 488-nm excitation wavelength, and sorting logic was controlled 
using log red versus log green fluorescence bit map gating. Cell 
aggregates and debris were eliminated using forward angle light 
scatter gates. Spectral overlap between cells stained with specific 
antibody and those incubated with FITC or PE isotype controls 
was electronically compensated using analog subtraction. Cells were 
sorted at a rate of m3,000 cells/second with coincidence abort en- 
gaged. Cells were sorted into three fractions: CD4+CD8 + DP and 
CD4+CD8 - and CD4-CD8 + SP cells. Sorted cells were analyzed 
for purity using machine parameters identical to those for sorting. 
In general, the populations were >98% pure with the majority 
of sorts yielding subsets of 99% purity. Contaminating cells were 
usually <1% CD4-CD8- double negative (DN) or DP in the SP 
fractions and CD4 + or CD8 + SP cells in the DP fraction. Sorted 
cells were washed and pelleted in PBS and frozen as dry pellets 
for detection of HIV DNA and KNA by PCR analysis. 
RNA and DNA PCR. DNA PCR was performed as previ- 
ously published (23). Briefly, frozen cell pellets were lysed at a con- 
centration of 10 s cells per 50 #1, and DNA from this number 
of cells analyzed. Primers used were SK38/39 (gag 1551-1578/ 
1638-1665) and SK70/JG69 (env 7841-7875/7959-7937) (Synthecell 
Corp., Rockville, MD). Reactions (50 #1 of DNA lysate, 50 pmol 
of each primer, 200 #M each of the four deoxynucleotide 
triphosphates [Boehringer Mannheim, Indianapolis, IN] 10 mM 
Tris-HC1, 2.5 mM MgClz, 50 mM KC1, 0.2% gelatin, and 2 U 
Taq polymerase [Perkin-Elmer Cetus, Norwalk, CT] in 100 #1 total 
volume) were run for 31 cycles of denaturation (94~ annealing 
(55~ and extension (72~ Amplified products were detected 
by liquid hybridization to 32p-labeled ATP end-labeled probes (SK 
19 [gag 1595-1635] or SK69 [env 7922-7942], respectively) and ana- 
lyzed on 10% polyacrylamide gels followed by exposure to film 
(Eastman Kodak Co., Rochester, NY) for varying lengths of time. 
For quantification fviral burden, serial dilutions of the lysed sample 
DNA were added to DNA from 10 s Jurkat cells and amplified as 
described. Signals on autoradiography were compared with those 
from simultaneously run dilutions of ACH-2 cells, a chronically 
infected T cell line that contains one provirus per cell, as previ- 
ously described (24). 
RNA PCR was performed according to the method of Graziosi 
et al. (25). Briefly, RNA was isolated from frozen cell pellets using 
the RNAzol method (Tel-Test, Inc., Friendswood, TX) followed 
by isopropanol and then ethanol precipitations. Samples were then 
treated with DNase (Boehringer Mannheim) at room temperature 
for 1 h with frequent vortexing, followed by heat inactivation of 
the DNase and immediate use of the samples in the PCR reaction. 
Reverse transcription and CDNA amplification were carried out 
in the same reaction mixture without addition of reagents between 
reactions, o that reverse transcription was directed by the antisense 
primer. The reaction mixture differed from that for DNA PCK 
only in that primers were used at 250 pmol each and 25-30 U AMV 
reverse transcriptase (K'I~ Life Sciences, Inc., St. Petersburg, FL) 
were added initially to each reaction. Reverse transcription was car- 
1152 HIV Infection of the Human Thymus/Thymic Disruption in SCID-hu Mouse 
tied out for 10 min at 42~ followed by amplification using the 
same parameters a those used for DNA PCR for 35 cycles. Reac- 
tion products were analyzed as for DNA PCR. SK38/39 primers 
with the SK19 probe were used to detect unspliced gag RNA and 
the TR-5/TR-3 (5953-5974/8414-8395) primer pair with the TR-4 
probe (5975-5999) used to detect spliced mRNA for the tat/rev 
messages. With each experiment, RNA was extracted in parallel 
from 8E5 cells, a chronically HIV-infected T cell line that constitu- 
tively expresses HIV (26). The isolated RNA was divided into two 
equal portions each representing the RNA derived from 1,000 cells 
and run either with or without he addition of the RT enzyme 
to serve as positive and negative controls. 
In Situ Hybridization/lmmunohistocheraistry. ISH/IHC was per- 
formed by a procedure described at length dsewhere (27). Briefly, 
silanized slides were deparafl~nized, acetyhted, and hybridized with 
a truncated HIV probe representing all of the HIV-1 genome. After 
hybridization, the slides were exhaustively washed, digested with 
RNase, and coated with Kodak NTB3 emulsion. After 4-d exposure, 
the slides were developed and stained with hematoxylin. Combined 
ISH/IHC stains were performed using the method escribed by 
Spiegel et al. (28). Lymphocyte mAbs used in this study were ob- 
tained from Dako Corp. (Carpinteria, CA), and AE1 and AE3 from 
Boehringer Mannheim. 
TEM. Small pieces (4-8, <1 mm) of thymic explant, fixed, 
at least overnight, in 2.5% glutaraldehyde (buffered to pH 7.2 with 
0.1 M Na cacodylate buffer), were postosmicated, dehydrated in 
increasing concentrations of ethanol and propylene oxide, and em- 
bedded in Spurr's epoxy (29). 1/~m, semi-thin plastic sections were 
cut with glass knives and stained with methylene blue, azure-II, 
and basic fuchsin. The sections were analyzed by light microscopy 
and at least wo blocks were sdected for ultrastructural study. Thin 
sections (600 A) were cut with diamond knives, mounted on copper 
grids, stained with uranyl acetate and lead citrate, and examined 
on a Zeiss EM 10 operating at 60 kv. 
Results 
Maturation of the Human Thymus inSCID-hu Mic~ SCID-hu 
mice were harvested atvarying times after intrathymic njec- 
tion of either sterile normal saline or HIV in saline. The typ- 
ical mock-infected thymic explant had a normal histologic 
appearance (Fig. 1 A), consistent with previous reports (17, 
18). Specifically, thymic lobules were present with normal 
appearing Hassall's corpusdes in the medullary region, and 
IHC staining for HLA-DR revealed a dense interconnected 
stromal network most striking in the medulla (Fig. 1 B), 
which is a previously reported normal finding in the human 
thymus (30). Thus, as demonstrated in these xperiments and 
previously (17, 18), the thymus which develops in the SCID-hu 
mouse appears to have the major features of normal human 
thymus. 
Histology of the HIV-infected Thymus. An HIV-infected 
thymus is shown in Fig. 1 C and differs markedly from the 
mock-infected thymus hown in Fig. 1 A. The HIV-infected 
thymic explant has a large fibrous component, more adipose 
tissue (suggestive of the occurrence of atrophy), less well 
demarcated cortical/medullary junctions, and varying numbers 
of preserved Hassall's corpuscles. ISH gives a signal consis- 
tent with the presence of large amounts of HIV RNA (Fig. 
1 D). In contrast to what has been shown previously in the 
infected hyperplastic lymph node, where much of the RNA 
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represents extraceUular virions attached to processes of fol- 
licular dendritic ells (31, 32), the HIV RNA detected in 
the thymus is most likely intraceilular mRNA since the signal 
does not increase after protease digestion (data not shown). 
When ISH for HIV was combined with IHC staining for 
a variety of antigens, it was found that both CD4 + and 
CD4- cells were infected with HIV whereas macrophages 
did not appear to be infected (data not shown). 
Two different viral isolates were used in these xperiments 
and varying degrees of thymocyte depletion were observed 
histologically. Fig. 2 shows several examples of thymuses that 
were stained for cytokeratins, a pink stain that specifically 
identifies the TE cell. At 8 wk after infection with the JR- 
CSF isolate, minimal thymocyte depletion was observed, and 
the densely packed thymocytes tend to obscure the under- 
lying TE cell network (Fig. 2 A). In comparison, Fig. 2 B 
shows a thymus harvested 3 wk after infection with the SM 
isolate. The diminished number of thymocytes allows one 
to now readily identify the presence of pink-stained, keratin- 
containing TE cells in an intricate supporting network. Similar 
thymocyte depletion was observed in thymuses infected with 
the JR-CSF isolate at 12 wk after infection with discrete foci 
of cells staining positively by ISH for HIV RNA clearly visible 
(data not shown). Some areas of these thymuses contained 
clearly identified TE cells that were negative by ISH for HIV 
in the same field as keratin-negative cells stained intensely 
positive by ISH that were likely thymocytes (Fig. 2 C). How- 
ever, further examination ofthese thymocyte-depleted tissues 
also revealed keratin-staining cells that were clearly positive 
by ISH for intracellular HIV RNA (Fig. 2 D). Thus, the 
use of HIV ISH combined with IHC for a variety of cell- 
associated antigens resulted in the identification of both 
CD4 + and CD4- HIV-infected thymocytes, as well as the 
detection of TE cells containing HIV RNA. 
Evaluation of Viral Burden and Viral Expression i Thymo- 
cytesfrom the SCID-hu Thymus. Because many of the HIV- 
positive cells on ISH were CD4- but appeared morpholog- 
ically to be thymocytes, we determined further which subsets 
of thymocytes were infected with HIV and the kinetics of 
this infection. Total thymocytes were harvested from the 
human thymic implants at progressively longer times after 
infection and sorted into highly purified SP (CD4 + SP or 
CD8 + SP) or CD4+/CD8 + DP subsets. Unfractionated 
total thymocytes were also analyzed. Fig. 3 shows the results 
of DNA PCR performed on sequentially obtained thymo- 
cyte subsets in one representative experiment using the HIV 
primary isolate JR-CSF for infection. By 1 wk after infec- 
tion, a positive signal forgag DNA can be seen in the unfrac- 
tionated, CD4 + SP and CD8 + SP subsets whereas the DP 
cells remain negative. Infection can be detected in the DP 
cells by the second week, with significant increases in viral 
burden occurring in all three cell subsets over the following 
2 wk (Fig. 3). In this particular experiment, the viral burden 
in the CD4 + SP subset at 1 wk is equivalent to or only 
slightly greater than that in the CD8 + SP subset (titration 
data not shown). However, results from two other experi- 
ments using this viral isolate revealed more clearly that the 
CD4 + SP cells are the initial subset of thymocytes infected, 
Figure 1. Histology of the mock- and HIV-infected SCID-hu human thymus. (A) A typical thymus harvested 2 wk after mock in~'tion and processed 
as described inMaterials and Methods. (x 16 magnified Giemsa stain). (B) Staining of the mock-infected thymus with anti-HLA-DR reveals a network 
of DR-positive processes, most prominent i  he medulla which contains a lower number of thymocytes. (C) A x20 magnified, Giemsa-stained section 
of thymus (2 wk after infection with JR-CSF) with fibro-adipose tissue (Ad), Hassall's corpuscles (arrow), and underlying mouse kidney (K). (D) Darkfield 
view of ISH staining for HIV RNA of a 2-wk JR-CSF-infected thymus. 
in that a positive DNA PCK signal was seen in only the 
unfractionated and CD4 + SP subsets at 3 d after infection, 
with the appearance of virus in the CD8 + SP or the DP 
cells lagging behind the CD4 + SP cells by 4-10 d. In four 
separate xperiments using the JR-CSF isolate, total viral 
burden at 8-12 wk after infection, determined by dilutional 
DNA PCK analysis, varied from 2 to 10% of total thymo- 
cytes and from 0.5 to 10% ofCD4 + SP, 2 to 10% ofCD8 + 
SP, and 0.5 to 5% of the DP cells. In all four experiments 
performed thus far with the JK-CSF isolate, viral burden in 
the CD8 + SP subset equaled or surpassed that of the CD4 § 
SP subset by 2-4 wk after infection (Fig. 3). Likewise, a con- 
sistent finding in all experiments u ing this isolate is the lower 
viral burden seen at later time points after infection in the 
DP thymocytes when compared with either of the SP frac- 
tions (Fig. 3). The positive PCK signals seen i the CD8 + 
thymocyte subset reflects true infection of these cells and could 
not be due to contamination of the CD8 + cells by infected 
CD4 + thymocytes, in that the subsets were >98% pure and 
the intensity of the PCR signals in the two subsets was similar. 
Indeed, quantitation of viral burden at later time points after 
infection always revealed an equal or greater burden in the 
CD8 + subset when compared with the CD4 + subset, as in- 
dicated by a stronger PCR signal on serial dilutional analysis 
in the CD8 + thymocytes (data not shown). 
In contrast with the infection kinetics and viral burden 
found using the JK-CSF isolate, the more virulent SM iso- 
late displayed an accelerated kinetics of infection, with marked 
thymocyte depletion occurring by 3 wk after infection, and 
a higher viral burden in the DP thymocyte subset han in 
either the CD4 + SP or CD8 + SP cells (viral burden at 3 
wk, "~50% of total thymocytes in two separate xperiments, 
with infection of 50% of the DP and 10% each of the 
CD4 + and CD8 + SP cells). Additionally, the thymocyte 
depletion which was so readily observed histologically (Fig. 
2) was reflected in a predominant loss of DP and CD4 + SP 
cells when the SM isolate was used (FACS ~ analysis of thymo- 
cytes from mock thymus revealed 78% DP, 14% CD4 +, 
7% CD8 + , and 1% DN compared to thymocytes from the 
3-wk SM-infected thymus which contained 9% DP, 5% 
CD4 + , 58% CD8 + , and 28% DN). In contrast, the JR- 
CSF isolate led to significant depletion of thymocytes much 
later after infection (week 12) and seemed to cause an overall 
decrease in all subsets with a significant loss of DP cells (FACS | 
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Figure 2. Thymocyte d pletion a d infection ofTE cells. Thymuses from SCID-hu mice were harvested at varying times after infection and examined 
for HIV RNA by ISH and stained with AE-1 antibody for identification f keratin-containing TE cells. (A) Thymus infected for 8 wk with JR-CSF, 
showing minimal thymocyte d pletion. Only faint pink (cytokeratin) staining of TE cells is visible because ofoverlying thymocytes. (B) Thymus infected 
with SM isolate for 3 wk with marked depletion of thymocytes r vealing the underlying TE cell network, stained positively for cytokeratins. (C)
This 12-wk JR-CSF--infected thymus reveals some thymocyte d pletion. A pink-stained, cytokeratin-containing TE cell is clearly seen which is negative 
for HIV by ISH staining (amav). In contrast, a cell stained intensely positive by ISH, indicating active HIV replication, is seen which does not stain 
for cytokeratins and is probably a thymocyte (arrowhead). (D) Thymus infected with JR-.CSF for 12 wk reveals aTE cell containing cytokeratins and 
staining positively for cytoplasmic HIV RNA by ISH (amav). 
analysis of thymocytes from mock-infected thymus revealed 
82% DP, 12% CD4 +, 6% CD8 +, and 1% DN compared 
with analysis of 12-wk JR-CSF-infected thymocytes showing 
51% DP, 22% CD4 +, 23% CD8 +, and 5% DN). These 
results are consistent with the thymocyte depletion seen by 
other investigators (33a) using these viral isolates in this model 
of infection. 
To evaluate whether the DNA PCR results indicated a
productive HIV infection of these various thymocyte subsets, 
RNA PCR was performed using primers to detect both struc- 
tural (gag) and spliced (tat/rev) KNAs. Fig. 4 is representa- 
tive of the results from three separate xperiments. At day 
14 large amounts of gag RNA were found in the unfraction- 
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ated and CD8 + SP cells while there was a lesser amount 
found in the DP and CD4 + SP fractions. By day 60, gag 
RNA had increased in all thymocyte subsets. These semi- 
quantitative RNA findings paralleled the relative viral burden 
detected in these four subsets by quantitative DNA PCR per- 
formed on duplicate pellets of cells in this experiment (data 
not shown). Messenger RNA for the spliced tat/rev message 
was also present in large amounts in the unfractionated and 
CD8 + SP cells at day 60 with smaller amounts present in 
the DP and CD4 + SP subsets (Fig. 4). In two separate ex- 
periments tat/rev mRNA was detected in the CD4 + and 
CD8 + subsets as early as 2 wk after infection, whereas it 
was first detected 30 d after infection in the DP fraction in 
Figure 3. Increasing viral burden in JK-CSF--infected SCID-hu thy- 
muses. SCID-hu mice were killed at increasing intervals after infection 
and total thymocytes were harvested, sorted into SP and DP subsets, and 
analyzed by DNA PCIL for the detection fHIV gag DNA, as described 
in Materials and Methods. Results from each thymocyte subset at various 
times after infection are shown, with positive and negative controls (bottom 
panel). Negative controls consist of mock (total thymocytes from two sep- 
arate mock infected mice), lysis buffer alone (LB), and lysate from the 
uninfected Jurkat cell ille. Positive controls shown are serial dilutions of 
lysate from the chronically HIV-infected ACH-2 cell ine representing DNA 
from 1,000, 100, 10, and 1 cells. Resuks are representative of four separate 
experiments involving infection with the JR-CSF isolate. 
one experiment (data not shown). Thus, productive infec- 
tion, as indicated by the presence of both structural nd regula- 
tory viral mRNAs, occurred in all three thymocyte subsets 
after inoculation of the thymus with HIV. 
Morphologic Patterns of HIV Infection of the Thymus. In ad- 
dition to the evaluation of individual cell types infected with 
HIV, the histology of the infected thymuses was ultrastruc- 
turaUy examined. In general, two morphologic patterns of 
HIV infection in the thymic tissue were observed, involving 
either predominantly hymocyte infection (Figs. 5 and 6, pat- 
tern 1) or destruction f TE cells with or without demon- 
strable virus within the cells (Figs. 7 and 8, pattern 2). Both 
morphologic patterns could occur in distinct areas of the same 
individual thymus. 
Examples of the first morphologic pattern, in which thymo- 
cytes are predominantly affected, are shown in Fig. 5. A mul- 
tinucleated giant cell is shown in a thymus infected with the 
SM isolate (Fig. 5 A). This cell is productively infected with 
HIV in that virions were seen budding from the cell surface 
Figure 4. Productive infection of thymocyte subsets with expression 
of both spliced and unspliced messages. RNA PCR was performed on 
RNA extracted from thymocyte subsets harvested and sorted at varying 
times after infection with JR-CSF, as described in Materials and Methods. 
Data shown are from a different experiment than that in Fig. 3, and are 
representative of RNA results obtained from three separate experiments. 
The results of R.NA-PCR analysis are shown using total RNA harvested 
from the following numbers ofavailable c lls: (d14) 106 unfractionated, 
DP, and uninfected, and 5 x 105 CD4+ and CD8 + SP; (drO) 4 x 105 
cells in all infected subsets for each primer pair, and 106 thymocytes from 
an uninfected thymus. 
(Fig. 5, inset). Indeed, when infected thymocytes were de- 
tected by TEM they often displayed multiple buds (Fig. 5 
B) indicating active localized viral replication. This TEM pat- 
tern is consistent with the findings on ISH in which labeling 
of tissue by the HIV-specific probe often indicated loci of 
individual cells possessing large amounts of HIV KNA (Fig. 
1 D). Infection of thymocytes in these thymuses ultimately 
resulted in thymocyte depletion, as is shown strikingly in 
Fig. 6. Fig. 6 A shows a mock-infected thymus in which 
the elongated desmosome-linked dendritic-like TE cell pro- 
cesses form a supporting stroma that surrounds individual 
thymocytes. In Fig. 6 B, a section of a thymus infected for 
3 wk with the SM isolate is hown in which the supporting 
TE cell stromal network appears to be relatively healthy and 
intact with preserved junctions between cells, whereas the 
loss of thymocytes is readily apparent in the abundant spaces 
left between TE cells. This marked thymocyte depletion was 
most easily observed by TEM with the rapidly cytopathic 
SM isolate as compared with the JK-CSF isolate, and occurred 
as early as 2-3 wk after infection. 
The second morphologic pattern observed in the HIV- 
infected thymuses involved the destruction of the thymic 
microenvironment, most notably infection and/or depletion 
of TE cells. A low power TEM view of a cell with morpho- 
logical features of a TE cell in a thymus infected for 2 wk 
with JR-CSF is shown in Fig. 7 C with higher power views 
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Figure 5. Morphologic pattern of HIV infection in the thymus with predominance of thymocyte involvement (pattern I). Infected thymuses were 
harvested at varying times after in~tion with either the SM or JR-CSF isolate of HIV and processed for TEM analysis as described in Materials and 
Methods. (,4) A multinucleated thymocyte, in a thymus infected with the SM isolate for 3 wk, with three plasma membrane particles (long and short 
arrows). (x 8,000). The inset is a higher magnification of one of the budding particles (short arrow). (x 110,000). (B) A small portion of the surface 
of a large multinucleated thymocyte in a thymus infected for 2 wk with JR-CSF with mature particles having a conical nucleoid (sh rt arrow) and 
several budding particles (long arrows). (x63,000). 
of this cell shown in the other panels. Although this cell ap- 
pears healthy, HIV is present, clustered both extracellularly 
(Fig. 7 B) and in vacuoles within the cell (Fig. 7, A and D). 
HIV was observed both in coated vacuoles (Fig. 7 D), pos- 
sibly indicating endocytosis of HIV by TE cells, as well as 
in multivesicular bodies, a component ofthe Golgi complex 
(Fig. 7 A). In the examination of multiple thymuses, HIV 
was frequently seen intimately associated with cells clearly 
identified as TE cells by the presence of desmosomes and in- 
tracellular tonofilaments. These data, in combination with 
the ISH/IHC data shown in Fig. 2 D, indicate that HIV 
is contained within TE cells in this model of human thymopoi- 
esis, although productive infection of these cells could not 
be formally demonstrated. 
Another feature of the second pattern of morphologic n- 
volvement of the thymus after HIV infection is shown in 
Fig. 8. In this thymus harvested 2 wk after infection with 
theJR-CSF isolate, no obvious infection of TE cells, thymo- 
cytes, or free HIV virions are seen i  this microscopic field, 
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yet marked toxicity to a portion of the TE cells has occurred. 
Healthy TE cells are seen in the periphery of the field, still 
attached by junctions to obviously abnormal vacuolated and 
degenerating TE cells. Despite this TE cell degeneration, the 
thymocytes within the field appear normal. These morpho- 
logic findings are consistent with a toxic insult to these par- 
ticular TE cells resulting in degeneration f this area of the 
supporting stromal network. 
Thus, one morphologic pattern is that of exuberant viral 
replication by individual thymocytes, formation of mul- 
tinucleated giant cells with budding virus, and marked thymo- 
cyte depletion. In contrast, asecond pattern involves altera- 
tion of the thymic microenvironment. In this pattern, TE 
cells contain HIV and are destroyed, either by HIV itself or 
by some currently unidentified HIV-associated toxic stimulus. 
Although both morphologies could be seen in the same 
thymus, infection with the SM isolate generally resulted in 
a predominance of thymocyte involvement whereas the JR- 
CSF isolate led to TE cell involvement and destruction in 
Figure 6. Thymocyte d pletion i the HIV-infected thymus compared with the normal thymus. (A) TEM of a fidd from a 2 wk mock-infected 
explant showing thymocytes intimately associated with the cell bodies and processes (long arrows) of four thymic epithelial cells. These TE cells have 
large nuclei with little heterochromatin nd one or two small nucleoli. Many electron-dense desmosomes join TE cells (short arrows). (B) An area of 
thymocyte drop-out isshown in a 3 wk SM-infected thymus, inwhich primarily empty spaces separate TE cells and their many processes. Abundant 
dectron-dense cytokeratin is seen in all of the TE cells (arrows). (x5,200). 
addition to the thymocyte infection readily detected by PCR 
analysis. 
Discussion 
This study demonstrates that intrathymic njection of pri- 
mary isolates of HIV results in the reproducible infection of 
multiple subsets of thymocytes a well as the presence of HIV 
within TE cells, leading to depletion of thymocytes and 
damage to the thymic microenvironment. Whereas DNA 
and RNA PCR analyses indicated productive infection of 
CD4 + and CD8 + SP as well as DP thymocytes, the pattern 
of infection and viral burden differed both within the three 
thymocyte subsets and between the two viral isolates used. 
These findings expand upon previous observations ofthymo- 
cyte depletion after infection of the SCID-hu mouse with 
primary isolates of HIV (33). 
The reproducible finding of HIV infection within the SP 
CD8 + thymocytes was surprising. Infection in this subset 
of cells could reflect infection of DP cells with a resultant 
decreased surface expression of the CD4 molecule. This seems 
somewhat unlikely, however, since the viral burden in the 
DP cells was always significantly less than that seen in the 
CD8 SP cells (using the JK-CSF isolate), and it is difficult 
to envision that modulation of the CD4 molecule could occur 
with such rapid kinetics to give these results. Alternatively, 
CD8 + cells, particularly more immature cells, may still 
possess a small amount of CD4 on their surface resulting 
in susceptibility of these cells to infection by HIV. The sub- 
sequent high viral burden observed in this subset might then 
reflect he balance between asimilar susceptibility of CD4 + 
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and CD8 § SP cells to infection and a lower HIV-induced 
cytotoxicity for the CD8 + cells, since cytotoxicity has pre- 
viously been positively correlated with levels of expression 
of CD4 on the surface of an infected cell (34, 35). A third 
potential explanation is that infection occurs in the so called 
"triple negative" (TN, CD3-CD4-CDS-)  thymic precursor 
cells, a subset hat has been previously demonstrated to be 
infectable in vitro (7). The infected TN cell might then be 
preferentially driven to mature along the CD8 SP pathway, 
resulting in an accumulation of infected CD8 + SP cells. 
Since TN cells comprise an extremely small percentage of 
the population of thymocytes harvested from these SCID-hu 
thymuses (cells staining negatively for both CD4 and CD8 
generally <1.5% by FACS | analysis, data not shown), it has 
not been possible thus far to purify these cells for detection 
of HIV infection. Finally, relatively mature SP CD8 + 
thymocytes could become infected in the thymic microen- 
vironment by a cell-cell mechanism, much like that which 
has been previously reported to occur after coculture with 
mature peripheral blood T cells from HIV-infected individ- 
uals (36). Whereas circulating mature CD8 + cells are not 
infected with HIV (23), De Maria et al. (36) demonstrated 
that coculture of mature peripheral blood CD8 + T cells 
with autologous infected CD4 + T cells from seropositive in- 
dividuals resulted in the ability to derive CD8 + T cell clones 
from these cultures which were productively infected with 
HIV. This in vitro infection was presumably the result of 
culturing the previously uninfected CD8 + T cells with a 
higher number or concentration f productively infected au- 
tologous CD4 + cells than that which is seen in the circula- 
tion in vivo. In this regard, the close environment ofthe SCID- 
hu human thymus may well provide an appropriate milieu 
such that cell-mediated infection of CD8 + SP thymocytes 
can occur. Since infected CD8 + cells are not seen in the pe- 
ripheral circulation of seropositive individuals, thefate of these 
cells is uncertain. Whether intrathymic death or tissue se- 
questration occurs remains an area for further evaluation. 
Studies are ongoing to delineate whether mature or imma- 
ture CD8 + thymocytes are infected with HIV and to deter- 
mine the mechanism of this inf~tion and the fate of these cells. 
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Figure 7. HIV within TE cells. An infected ~ttened TE cell from a 
2 wk JR-CSl~--infected thymus i  shown in panel c with higher magnifica- 
tions of several of its associated virions al o shown. The lettered arrows 
in c refer to areas of the cell shown in the corresponding pands. (a) A 
mature particle is seen within a multivesicular body (cytophsmic vacuole). 
(b) A budding partide and several mature particles are seen along the plasma 
membrane ofthe cell. The eaact cen from which these virions originated 
cannot be determined. (c) The TE cell in dose contact with several thymo- 
cytes. (d) A mature partide within a coated vesicle (lower/eft) is observed 
in the cytoplasm of this TE cell in a different section but in the approxi- 
mate area indicated by arrow d in c. a, b, and d, • 110,000; c, x 10,000. 
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Figure 8. TE cell degeneration n the infected thymus. In this thymus harvested 2 wk after infection with JR-CSF, more normal-appearing TE 
cell processes (p), with occasional swollen mitochondria and electron-dense lipid vacuoles (long arrow pointing to mitochondrion t uching lipid vacuole) 
are attached by desmosomes (short arrows) to the dectron-lucent degenerating TE cells (d). No virions are seen in this rid& (x6,500). 
Involvement of the TE cell in this infected tissue was ex- 
amined by both TEM and ISH/IHC techniques. IHC/ISH 
double labeling demonstrated the pr sence of keratin-con- 
taining TE cells stained positively for HIV RNA, whereas 
TEM examination revealed HIV intracellularly and intimately 
associated with TE cells, although budding virus could not 
be definitively shown. In this regard, it is possible that the 
positive signal seen by ISH in TE cells may reflect he pres- 
ence of intracellular viral RNA and not mRNA, and the in- 
ternalization of virus may not result in productive infection 
of these cells. Nevertheless, the demonstration f intracel- 
lular HIV in TE cells in the SCID-hu human thymus is of 
considerable interest. Previous tudies (12-16) have demon- 
strated that thymuses from HIV-infected individuals are 
markedly abnormal and display evidence of premature invo- 
lution and TE cell toxicity. Whereas ISH results obtained 
by Schuurman et al. (14) were suggestive of TE cell infec- 
tion, this phenomenon has not been definitively demonstrated 
in vivo. In vitro infection of cultured TE cells has been ac- 
complished resulting  a transient low level production of 
p24 and TE cell death by 8-10 d (37), although it is unclear 
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whether contaminating thymocytes orother cells were present 
in the initial cultures. Our data indicate that TE cells be- 
come infected with HIV in vivo, but the presence of HIV 
did not seem to correlate with destruction of the TE cell. 
This difference in TE cell cytopathology could be due to the 
differences between an in vivo versus an in vitro systom. As 
an example, HLA-DK is constitutively expressed by TE cells 
in the thymus, whereas cultured TE cells do not express this 
antigen unless exogenous IFN-y is added to the media (38). 
Additionally, there are multiple subtypes of TE cells within 
the thymus representing different stages of maturation and 
different functions and containing variable amounts of cytoker- 
atins (30). These can be identified by the expression of an- 
tigens that distinguish medullary and subcapsular endocrine 
functioning TE cells from the cortical TE cells. In fact, as 
many as six different ypes of TE cells have been identified 
ultrastructurally (39). Studies are ongoing to determine 
whether there are differences in susceptibility o HIV infec- 
tion among TE cell subsets and to delineate any functional 
alterations that may occur in these cells. The lack of toxicity 
noted in TE cells containing HIV (e.g., Fig. 7) might be a 
function of the timing of tissue harvest after infection, or 
may indicate that infection in vivo is chronic, noncytopathic, 
and nonproductive or associated with low levels of virus 
production, similar to the pattern of infection observed in 
tissue macrophages. In this regard, the majority of imma- 
ture particles een in these tissues were budding from thymo- 
cytes, suggesting that the virus within TE cells is indeed ei- 
ther nonreplicative orassociated with only a low level of virus 
production as compared with thymocytes. This would have 
significant implications for the potential role of these cells 
as a viral reservoir in which newly developing and suscep- 
tible thymocytes are chronically exposed to HIV. Current 
studies in this laboratory are addressing these issues. 
TE cell toxicity was noted that was seemingly unrelated 
to productive infection of these cells. One can speculate that 
infection and destruction of thymocytes could result in their 
failing to produce TE trophic factors uch as IFN-3' or IL-2, 
resulting in death of the TE cells. However, in some instances 
we have observed estruction of TE cells before depletion 
of thymocytes. Alternatively, cross-reactivity occurs between 
the HIV p19 and gp41 proteins and TE cell antigens uch 
as HLA-DR (40, 41), such that an immune response mounted 
against HIV might target normal TE cells. However, this 
is unlikely to occur in the SCID-hu thymus. It is dear that 
the thymic microenvironment is a complex tissue requiring 
the intact function of thymocytes, TE cells, and even fibro- 
blasts (30) for normal development, growth, and T cell matu- 
ration. The mechanism by which HIV disrupts this environ- 
ment is an area of ongoing investigation. 
In summary, infection of the human thymus in the SCID-hu 
mouse results in infection of both distinct hymocyte subsets 
and TE cells. Thymocyte depletion and TE cell degeneration 
occur. The depletion of thymocytes by HIV infection and, 
in particular, the ability of HIV to disrupt the TE cell sup- 
porting framework of the thymus, has broad implications 
for therapies aimed at reconstitution of the immune system 
in HIV-infected individuals. 
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